Farther Finance Advisors
LYEL icon

Farther Finance Advisors’s Lyell Immunopharma LYEL Stock Holding History

Farther Finance Advisors’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.41K Buy
+144
New +$1.92K ﹤0.01% 5490
2024
Q1 		– Hold
0
– -$2 – 3671
2023
Q4 		– Hold
0
– – – 3541

Other funds holding LYEL

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors's LYEL Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Lyell Immunopharma (LYEL) in Q3 2026: 144 shares worth $1.41K. The stake represents ﹤0.01% of the portfolio and ranks #5490 among its holdings.

5 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.

  • Farther Finance Advisors held 144 shares of Lyell Immunopharma worth $1.41K as of Q3 2026.
  • Lyell Immunopharma was a new Farther Finance Advisors position in Q3 2026.
  • Lyell Immunopharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5490 holding.
  • 5 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.